Pharma-Bio Serv, Inc. (PBSV) stock: key figures, P/E, revenue and dividend
Industrials · United States · ISIN US71711N1000
Pharma-Bio Serv, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 9.00 m USD |
| Gross profit | 2.91 m USD |
| Operating income | -637,662.00 USD |
| EBIT | -131,786.00 USD |
| Net income | -100,463.00 USD |
| Diluted EPS – continuing operations | -0.00 USD |
Full history since 2007, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Pharma-Bio Serv, Inc.
Pharma-Bio Serv, Inc. operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company offers a broad range of technical compliance consulting services, including regulatory affairs, quality assurance, compliance, technology transfer, validation, engineering, project management, and process support. It serves pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.
More stocks
- MINERALRITE Corp (RITE)
- Hepion Pharmaceuticals, Inc. (HEPA)
- Tempus AI, Inc. (TEM)
- Fabric.AI, Inc. (FABC)
- Aspire Biopharma Holdings, Inc. (ASBP)
- T Stamp Inc (IDAI)
- VIP Play, Inc. (VIPZ)
- Next Technology Holding Inc. (NXTT)
- Genvor Inc (GNVR)
- BION ENVIRONMENTAL TECHNOLOGIES INC (BNET)
- RESEARCH FRONTIERS INC (REFR)
- GUIDED THERAPEUTICS INC (GTHP)
Not investment advice. All data without warranty, price as of 17.11.2026. Details in the risk notice.